How do rates of hospitalization and death in those 60 and older compare for RSV and influenza? A meta-analysis explored this question.

Researchers evaluated whether metformin use prior to hospitalization for community-acquired pneumonia decreases the risk of mortality in older patients with diabetes.

Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.

How effective was the 2021-2022 influenza season vaccine against A(H3N2) outpatient illness, and how did the vaccine’s effectiveness vary by age group?

A meta-analysis examined the effect of undernutrition on treatment outcomes and sputum culture conversion in individuals with multidrug-resistant TB.

How did relaxation of pandemic-related restrictions affect asthma exacerbations, and what does this show about the association between asthma, COVID-19, and other ARIs?

How well does a positive anti-Mycobacterium avium complex antibody test predict a diagnosis of nontuberculous mycobacterial pulmonary disease?

The 20vPnC vaccine consists of capsular polysaccharide conjugates for the 13 serotypes included in Prevnar 13, along with 7 additional serotypes that cause invasive pneumococcal disease.

A Maryland study identified patterns of RSV and HPIV-3 in children aged 0 to 4 years later in the pandemic, from November 2020 to March 2021.

Researchers examined the relationship between early childhood lower respiratory illnesses and structural lung changes in young adults.

Researchers compared the efficacy of azithromycin vs placebo to treat lower respiratory tract infections in patients with low procalcitonin levels.

Researchers examined the association between pneumococcal carriage and COVID-19 infection.

Which influenza symptoms persist throughout the infection course, and which symptoms occur in the earlier vs later course of an influenza infection?

A systematic review and meta-analysis of nontuberculous mycobacterial pleuritis detailed patient characteristics, clinical presentations, and outcomes.

In a population-based study, researchers assessed the risk for stroke following influenza vaccination in adults.

The combined vaccine is intended to simplify immunization practices against 2 severe respiratory diseases caused by evolving viruses that require vaccine adaptation.

A meta-analysis of 2000 to 2001 data estimated the disease burden of respiratory syncytial virus among adults at least 60 years of age in high-income countries.

A meta-analysis assessed exercise capacity, as measured by CPET, more than 3 months after COVID-19 infection in those with and without long COVID symptoms.

A New Zealand population study examined the effect of maternal influenza vaccination on birth outcomes.

The BLA is supported by data from the phase 3 RENOIR trial which included approximately 37,000 adults 60 years of age and older.

Is there an association between drug use and severe influenza-associated outcomes, including ICU admission, mechanical ventilation, and death?

Are changes in exercise habits among those with bronchiectasis associated with reduced cardiovascular disease risk — and how much exercise is optimal?

Researchers evaluated the effect of influenza vaccination on reducing antibiotic prescription outcomes for adults diagnosed with influenza-like illness.

Researchers evaluated whether finerenone treatment protects against pneumonia and COVID-19 in patients with chronic kidney disease and type 2 diabetes.

Investigators assessed the relationship between COVID-19 illness severity and post-COVID dyspnea, exercise capacity, spirometry, and gas exchange.

How do outcomes of lung transplantation for COVID-19-related lung disease compare with those of patients receiving lung transplants for other causes?

A systematic review and meta-analysis assessed treatment outcomes and complication rates of adjunctive surgery in patients with NTM-PD.

Researchers identified microbiologic patterns associated with the overuse of empiric antibiotic therapy in patients with COPD who are hospitalized for CAP.

Researchers evaluated outcomes among children hospitalized with influenza who received early treatment with oseltamivir.

Researchers hypothesized a PCN allergy label in patients with bacterial pneumonia led to worse outcomes due to delayed and/or less effective antibiotic treatment.